Literature DB >> 8413312

Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation.

K J Kaneko1, J D Furlow, J Gorski.   

Abstract

The estrogen receptor (ER) appears to be down-regulated by its own ligand in some estrogen (E2)-responsive tissues as well as in cell lines such as MCF-7 and GH3. Surprisingly, we observed ER down-regulation in a newly constructed E2-responsive cell line (Rat1 + ER), in which expression of the coding region of the ER cDNA was driven by the Moloney murine leukemia virus long terminal repeat. We present evidence that the coding region of the ER cDNA, but not the Moloney murine leukemia virus long terminal repeat, possesses a sequence(s) necessary for ER down-regulation. The observed down-regulation occurs at ligand-binding and protein, as well as mRNA, levels. Marked decreases in both protein and mRNA levels were observed as early as 3 h after E2 treatment. Furthermore, maximal down-regulation occurred by 18-24 h with ligand-binding, and mRNA levels reached approximately 20% that of controls. ER down-regulation in Rat1 + ER cells is only partially inhibited by the presence of cycloheximide and therefore suggests a direct participation of the ER in this process. E2 does not appear to influence the stability of the ER transcript, which implies that negative regulation is occurring at the transcriptional level. Finally, since we can demonstrate ER binding to a portion of the cDNA sequence, we propose a mechanism whereby ER binding to its putative negative element leads to transcriptional repression of the upstream promoter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413312     DOI: 10.1210/mend.7.7.8413312

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

Review 1.  The Estrogen Receptor α-Cistrome Beyond Breast Cancer.

Authors:  Marjolein Droog; Mark Mensink; Wilbert Zwart
Journal:  Mol Endocrinol       Date:  2016-08-04

2.  [Leu5]enkephalin-encoding sequences are targets for a specific DNA-binding factor.

Authors:  G Bakalkin; M Telkov; T Yakovleva; L Terenius
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

3.  Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy.

Authors:  Y J Lee; J Gorski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 4.  Molecular aspects of estrogen receptor variants in breast cancer.

Authors:  S A Fuqua; D M Wolf
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

5.  A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7.

Authors:  J J Pink; S Q Wu; D M Wolf; M M Bilimoria; V C Jordan
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

6.  PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.

Authors:  Carolina Cristina; Graciela S Díaz-Torga; Rodolfo G Goya; Sham S Kakar; María I Perez-Millán; Vanessa Q Passos; Daniel Giannella-Neto; Marcello D Bronstein; Damasia Becu-Villalobos
Journal:  Mol Cancer       Date:  2007-01-12       Impact factor: 27.401

7.  Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.

Authors:  Anders E A Dahm; Nina Iversen; Baard Birkenes; Anne Hansen Ree; Per Morten Sandset
Journal:  BMC Cardiovasc Disord       Date:  2006-10-09       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.